Breast Imaging Technologies Market Report 2026

Breast Imaging Technologies Market Overview

• Breast Imaging Technologies market size has reached to $5.21 billion in 2025 • Expected to grow to $7.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.4% • Growth Driver: Growing Prevalence Of Breast Cancer • Market Trend: AI-Enabled Ultrasound Innovations Expanding Capabilities In Breast Imaging • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Breast Imaging Technologies Market?

Breast imaging technologies refer to a subspecialty of diagnostic radiology and medical imaging techniques used to detect and examine the breast tissue for signs of disease or abnormality in the early stages. It is used in several clinics as an additional screening tool for breast-dense women and assess results from breast ultrasonography and mammography. The main types of imaging techniques used in breast imaging technologies are mammography, breast ultrasound, breast MRI, image-guided breast biopsy, positron emission tomography and others. Mammography refers to a breast imaging technology that uses low-dose X-rays to produce images of the breast tissue and is the most commonly used screening tool for breast cancer. The various technologies involved such as ionizing breast imaging technology and non-ionizing breast imaging technology, that are used by hospitals, diagnostic imaging center and others.

What Is The Breast Imaging Technologies Market Growth Forecast?

The breast imaging technologies market size is expected to see strong growth in the next few years. It will grow to $7.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to increasing integration of ai-based diagnostics, rising demand for non-invasive imaging techniques, expansion of personalized oncology care, growing investments in imaging infrastructure, increasing use of multimodal imaging platforms. Major trends in the forecast period include increasing adoption of ai-assisted breast imaging systems, rising demand for 3D mammography solutions, growing use of advanced breast mri techniques, expansion of image-guided biopsy technologies, enhanced focus on early cancer detection.

Global Breast Imaging Technologies Market Segmentation

1) By Imaging Modality: Mammography, Breast Ultrasound, Breast MRI, Image Guided Breast Biopsy 2) By Technology: Ionizing Breast Imaging Technology, Non-Ionizing Breast Imaging Technology 3) By End User: Hospital, Diagnostic Imaging Centre, Other End Users Subsegments: 1) By Mammography: Digital Mammography, 3D Mammography 2) By Breast Ultrasound: Handheld Ultrasound, Automated Breast Ultrasound, Contrast-Enhanced Ultrasound 3) By Breast MRI: Breast MRI With Contrast, MRI-Guided Biopsy 4) By Image Guided Breast Biopsy: Stereotactic Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy

What Is The Driver Of The Breast Imaging Technologies Market?

The growing prevalence of breast cancer is expected to propel the breast imaging technologies market going forward. Breast cancer refers to the type of cancer that starts in the cells of the breast in women. Breast tumors are formed when breast cells mutate (alter) and grow out of control. Breast imaging technologies are primarily used for the detection, diagnosis, and staging of breast cancer at an early stage, when it is most treatable. For instance, in May 2025, according to the American Cancer Society US-based, in 2025, there are projected to be 316,950 new cases of invasive breast cancer in U.S. women, along with 59,080 new cases of ductal carcinoma in situ (DCIS). Therefore, the growing prevalence of breast cancer is driving the growth of the breast imaging technologies industry.

Key Players In The Global Breast Imaging Technologies Market

Major companies operating in the breast imaging technologies market are Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., Hologic Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Canon Inc., Koning Corporation, Agfa-Gevaert N.V., Allengers Medical Systems Ltd., Planmed Oy, Metaltronica S.p.A., Esaote S.p.A., Bruker Corporation, Carestream Health Inc., Delphinus Medical Technologies Inc., Dilon Technologies Inc., Gamma Medica Inc., Micrima Limited, SuperSonic Imagine, Konica Minolta Inc.

Global Breast Imaging Technologies Market Trends and Insights

Major companies operating in the breast imaging technologies market are focusing on developing advanced ultrasound solutions, such as AI-enhanced automated breast ultrasound (ABUS) systems, to improve lesion detection, optimize scan consistency, and enhance workflow efficiency. AI-enhanced ABUS systems integrate intelligent scan guidance and high-performance transducers to deliver more uniform breast coverage and support early identification of abnormalities, particularly in women with dense breast tissue. For instance, in March 2025, GE HealthCare Technologies Inc, a US-based medical technology company, launched the Invenia ABUS Premium, its next-generation AI-driven automated 3D breast ultrasound system. The solution features AI-powered Scan Quality Assessment to ensure proper breast coverage and a Fast Scan tool that increases scanning speed by up to 40%, supporting greater diagnostic accuracy and improved clinical efficiency.

What Are Latest Mergers And Acquisitions In The Breast Imaging Technologies Market?

In August 2023, Solis Mammography, a US-based healthcare provider offering breast screening and diagnostic services, acquired Carolina Breast Imaging for an undisclosed amount. The acquisition significantly expanded Solis Mammography's presence in the breast imaging market, particularly in eastern North Carolina, enabling the extension of Carolina Breast Imaging’s services across Solis Mammography's network, advancing next-generation innovation, and fostering accessible community-based women’s imaging networks. Carolina Breast Imaging is a US-based company that specializes in providing breast imaging and early detection of breast cancer.

Regional Outlook

North America was the largest region in the breast imaging technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global breast imaging technologies market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Breast Imaging Technologies Market?

The breast imaging technologies market consists of revenues earned by entities by providing cone beam computed tomography (CBCT), molecular breast imaging (MBI), breast specific gamma imaging (BSGI), nuclear medicine imaging, and 3D breast tomosynthesis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast imaging technologies market also includes sales of x-ray generators, image detectors and breast compression paddle which are used in providing breast imaging technologies services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.